A detailed history of Kornitzer Capital Management Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Kornitzer Capital Management Inc holds 156,165 shares of NVO stock, worth $18.6 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
156,165
Previous 155,218 0.61%
Holding current value
$18.6 Million
Previous $19.9 Million 11.85%
% of portfolio
0.44%
Previous 0.38%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$122.71 - $146.91 $116,206 - $139,123
947 Added 0.61%
156,165 $22.3 Million
Q4 2023

Jan 31, 2024

BUY
$87.78 - $105.45 $100,595 - $120,845
1,146 Added 0.74%
155,218 $16.1 Million
Q3 2023

Oct 31, 2023

BUY
$90.94 - $199.54 $7.01 Million - $15.4 Million
77,036 Added 100.0%
154,072 $14 Million
Q4 2022

Feb 02, 2023

SELL
$102.55 - $135.33 $3,589 - $4,736
-35 Reduced 0.05%
77,036 $10.4 Million
Q3 2022

Nov 03, 2022

BUY
$95.28 - $116.93 $98,614 - $121,022
1,035 Added 1.36%
77,071 $7.68 Million
Q1 2022

Apr 27, 2022

BUY
$93.1 - $112.54 $3,351 - $4,051
36 Added 0.05%
76,036 $8.44 Million
Q1 2021

Apr 30, 2021

SELL
$67.06 - $75.82 $7,778 - $8,795
-116 Reduced 0.15%
76,000 $5.12 Million
Q3 2020

Oct 30, 2020

BUY
$63.69 - $70.22 $7,388 - $8,145
116 Added 0.15%
76,116 $5.29 Million
Q2 2020

Aug 03, 2020

BUY
$58.54 - $67.94 $878,100 - $1.02 Million
15,000 Added 24.59%
76,000 $4.98 Million
Q1 2020

Apr 30, 2020

BUY
$49.46 - $64.78 $738,437 - $967,165
14,930 Added 32.41%
61,000 $3.67 Million
Q4 2019

Jan 31, 2020

BUY
$49.86 - $58.26 $252,790 - $295,378
5,070 Added 12.37%
46,070 $2.67 Million
Q3 2019

Nov 04, 2019

BUY
$47.54 - $53.43 $1.95 Million - $2.19 Million
41,000 New
41,000 $2.12 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $269B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Kornitzer Capital Management Inc Portfolio

Follow Kornitzer Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.